Last reviewed · How we verify
Biopsies
At a glance
| Generic name | Biopsies |
|---|---|
| Sponsor | Centre Hospitalier Universitaire Dijon |
| Modality | Biologic |
| Therapeutic area | Other |
| Phase | discontinued |
Approved indications
Common side effects
Key clinical trials
- Diagnostic and PROgnostic BIOmarkers Before and After Kidney Transplantation (N/A)
- Cellular Mechanisms for Metabolic Dysfunction in HIV (Phase 1)
- Mobilization of Leukemic Cells Using Plerixafor as Part of a Myeloablative Preparative Regimen for Patients With AML Undergoing Allografting: Assessment of Feasibility and Efficacy (N/A)
- Evaluation of the Potential Association Between 5α-reductase Inhibitors Prescription and Occurrence of High Grade Prostate Cancers (N/A)
- Analysis of Dendritic Cells in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation (N/A)
- Response to Ustekinumab for Anti-tnf Induced Psoriasiform Skin Lesions (Phase 4)
- The Effectiveness and Safety of Percutaneous Lung Biopsy Guided by Electromagnetic Navigation Real-time Positioning Technology (NA)
- Implementing Precision Medicine for Glomerular Diseases in the Nephrotic Syndrome Study Network (NEPTUNE) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |